Table 2.

HPV vaccine recommendation quality indicators

n (%)
Timeliness
 For males: start routinely recommending HPV vaccine…
  Early/on time (≤12 y)472 (61)
  Late/never (≥13 y)304 (39)
 For females: start routinely recommending HPV vaccine…
  Early/on time (≤12 y)573 (74)
  Late/never (≥13 y)203 (26)
Consistency
 Use a risk-based approach to recommending HPV vaccine
  Strongly/somewhat disagree316 (41)
  Strongly/somewhat agree/neither agree nor disagree460 (59)
Urgency
 Usually recommend 11- to 12-year-olds get HPV vaccine…
  At current visit399 (51)
  At later visit/give a choice/other377 (49)
Strength of endorsement
 Say HPV vaccine for 11- to 12-year-olds is…
  Very/extremely important568 (73)
  Not/slightly/moderately important208 (27)

NOTE: For each variable the higher quality response is listed first.